AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Metrics to compare | ASTR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipASTRPeersSector | |
|---|---|---|---|---|
P/E Ratio | 106.8x | 26.8x | −0.5x | |
PEG Ratio | 0.99 | 0.67 | 0.00 | |
Price / Book | 26.8x | 4.2x | 2.6x | |
Price / LTM Sales | 9.9x | 4.0x | 3.2x | |
Upside (Analyst Target) | - | 29.0% | 45.7% | |
Fair Value Upside | Unlock | 5.4% | 4.8% | Unlock |